| LINE ITEM (USD / %) | FY 2025
FILED 2026-04-30 | FY 2024
FILED 2025-04-30 | FY 2023
FILED 2024-04-30 |
|---|---|---|---|
| Revenue (Total Sales) | $250.3M | $389.1M | $310.6M |
| YoY Revenue Growth % | -35.7% | +25.3% | — |
| Gross Profit | $77.4M | $235.9M | — |
| Gross Margin % | 30.9% | 60.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$498.5M | -$324.4M | -$318.3M |
| Operating Margin % | -199.2% | -83.4% | -102.5% |
| Net Income (GAAP) | -$470.4M | -$288.7M | -$279.7M |
| EBITDA (Normalized) | -$497.0M | -$322.0M | -$307.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$190.2M | -$41.4M | -$62.4M |
| Capital Expenditures (CapEx) | $1.9M | $3.0M | $14.0M |
| Free Cash Flow (FCF) | -$192.1M | -$44.4M | -$76.3M |
| FCF Margin % | -76.8% | -11.4% | -24.6% |
| Return on Invested Capital (ROIC %) | -45.0% | -31.1% | -38.7% |
| Cash & Short-Term Equivalents | $88.8M | $125.1M | — |
| Total Debt (Short + Long Term) | $79.3M | $87.7M | $251.8M |
| Total Stockholders' Equity | $719.5M | $860.2M | $516.6M |